ArticleCancer research communications2025

PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma.

Luiza Doro Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.